Sphingomyelin Synthase 1 (SMS1) Downregulation Is Associated With Sphingolipid Reprogramming and a Worse Prognosis in Melanoma

Sphingolipid (SL) metabolism alterations have been frequently reported in cancer including in melanoma, a bad-prognosis skin cancer. In normal cells, de novo synthesized ceramide is mainly converted to sphingomyelin (SM), the most abundant SL, by sphingomyelin synthase 1 (SMS1) and, albeit to a less...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Fatima Bilal, Anne Montfort, Julia Gilhodes, Virginie Garcia, Joëlle Riond, Stéphane Carpentier, Thomas Filleron, Céline Colacios, Thierry Levade, Ahmad Daher, Nicolas Meyer, Nathalie Andrieu-Abadie, Bruno Ségui
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2019-04-01
Serie:	Frontiers in Pharmacology
Soggetti:	sphingolipids ceramide glucosylceramide prognosis biomarker cancer
Accesso online:	https://www.frontiersin.org/article/10.3389/fphar.2019.00443/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!